Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy

Part of paid clinical trials in Birmingham, Alabama.

Sponsor
Sequenom, Inc.
Study ID
NCT01429389
Status
Recruiting

Conditions

  • Down Syndrome
  • Fetal Aneuploidy

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.

Key Dates

Start date
May 31, 2011
Status verified
Oct 2024
Primary completion
Dec 31, 2025
Completion
Mar 31, 2026

Study Design

Enrollment
2,000 participants (estimated)

Locations (12)

FacilityCityStateZIPSite coordinators
University of Alabama BirminghamBirminghamAlabama35294
Rachel Copper
205 934-5509
Joseph Biggio, MD
Cedars-Sinai Medical CenterLos AngelesCalifornia90048
Deebra Smith, MD
310- 423-5860
John Williams, MD
Sharp-Rees Stealy Medical GroupSan DiegoCalifornia92101
Mary LaPage
619 446-1624
Denis Tarakjian, MD
Specialty Obstetrics of San DiegoSan DiegoCalifornia92130
Deborah Malone
858 794-7700
David Dowling, MD
UCSDSan DiegoCalifornia92121
Jason Chibuck
Andrew Hull, MD
Women's Health Care ResearchSan DiegoCalifornia92123
Nora Martinez
858 505-8672
Rovena Reagan, MD
Reproductive Genetics InstituteChicagoIllinois60602
Denise Ginsberg
773 472-4900
Norman Ginsberg, MD
University of Iowa Health CareIowa CityIowa52242
Diedre Fleener
319 356-2913
Kristi Borowski, MD
Henry Ford HospitalDetroitMichigan48202
Ellen Martindell
313 916-3190
Jacquelyn Roberson, MD
Spectrum HealthGrand RapidsMichigan49503
Yvonne Edgerly
616 391-5066
Asad Sheikh, MD
The Cooper Health SystemCamdenNew Jersey-
Clare Hanson
Meena Khandelwal, MD
Medical University of South CarolinaCharlestonSouth Carolina29466
Betty Oswald
843 792-0347
Christopher Robinson, MD

Find similar trials in Birmingham, AL

Related Studies